{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:35:53Z","timestamp":1791182153182,"version":"4.1.0"},"reference-count":63,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[1999,4]]},"abstract":"<jats:p> PURPOSE: The successful treatment of Hodgkin's disease has been associated with an increased incidence of secondary malignancies. To investigate whether genetic factors contribute to the development of secondary tumors, we collected family cancer histories and performed mutational analysis of the ataxia-telangiectasia (AT) gene, ATM, in a cohort of Hodgkin's disease survivors with secondary malignancies. ATM was chosen for evaluation because of the increased radiosensitivity of cells derived from AT patients and obligate heterozygotes and the epidemiologic observation that AT carriers are at increased risk for radiation-induced breast cancer. <\/jats:p><jats:p> PATIENTS AND METHODS: Fifty-two patients who developed one or more neoplasms after treatment for Hodgkin's disease participated in this study. Personal and family histories of cancer were obtained through patient interviews and review of medical records. ATM mutational analysis was performed using a yeast-based protein truncation assay. <\/jats:p><jats:p> RESULTS: Seventy-six secondary neoplasms were observed in this cohort of 52 Hodgkin's disease survivors, with 18 patients (35%) developing more than one secondary neoplasm. Positive family histories of cancer were present in 11 (21%) of 52 patients, compared with three (4%) of 68 Hodgkin's disease patients in a comparison cohort who did not develop secondary neoplasms (P = .008; Fisher's exact test). No germline ATM mutations were identified, resulting in an estimated AT carrier frequency in this population of 0% (90% confidence interval, 0% to 4%). <\/jats:p><jats:p> CONCLUSION: Analysis of the number of tumors per individual and the family history of cancer in our cohort suggests that genetic factors may contribute to development of secondary neoplasms in a subset of Hodgkin's disease survivors. Mutational analysis, however, does not support a significant role for heterozygous truncating ATM mutations. Future studies evaluating other genes involved in DNA damage response pathways are warranted. <\/jats:p>","DOI":"10.1200\/jco.1999.17.4.1259","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:21:13Z","timestamp":1487917273000},"page":"1259-1259","source":"Crossref","is-referenced-by-count":51,"title":["Heterozygous Germline <i>ATM<\/i> Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease"],"prefix":"10.1200","volume":"17","author":[{"given":"Kim E.","family":"Nichols","sequence":"first","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Levitz","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen E.","family":"Shannon","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doke C.R.","family":"Wahrer","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne W.","family":"Bell","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Chang","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Hegde","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Shafman","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Tarbell","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mauch","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikashi","family":"Ishioka","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Haber","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Diller","sequence":"additional","affiliation":[{"name":"From the Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA; Departments of Pediatric Oncology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA; Joint Center for Radiation Therapy, Boston, MA; and Tohoku University, Sendai, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1-1259","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2"},{"key":"R2-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341201"},{"key":"R3-1259","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841115)54:10<2234::AID-CNCR2820541028>3.0.CO;2-6"},{"key":"R4-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341210"},{"key":"R5-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.2016"},{"key":"R6-1259","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.1.25"},{"key":"R7-1259","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3625.bloodjournal8793625"},{"key":"R8-1259","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90880-P"},{"key":"R9-1259","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00371-4"},{"key":"R10-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.536"},{"key":"R11-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1674"},{"key":"R12-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197712082972303"},{"key":"R13-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.6.830"},{"key":"R14-1259","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.23.1932"},{"key":"R15-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2205"},{"key":"R16-1259","unstructured":"Mauch  P,  Kalish  L,  Marcus  K, et al: Long-term survival in Hodgkin's disease.  Cancer J Sci Am 1:33,1995-42,"},{"key":"R17-1259","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008238908676"},{"key":"R18-1259","unstructured":"Swift  M,  Morrell  D,  Cromartie  E, et al: The incidence and gene frequency of ataxia-telangiectasia in the U.S.  Am J Hum Genet 39:573,1986-583,"},{"key":"R19-1259","doi-asserted-by":"publisher","DOI":"10.1126\/science.7792600"},{"key":"R20-1259","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870020412"},{"key":"R22-1259","unstructured":"Morrell  D,  Cromartie  E,  Swift  M: Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.  J Natl Cancer Inst 77:89,1986-92,"},{"key":"R23-1259","doi-asserted-by":"crossref","unstructured":"Morrell  D,  Chase  CL,  Swift  M: Cancers in 44 families with ataxia-telangiectasia.  N Engl J Med 325:1831,1990-1836,","DOI":"10.1056\/NEJM199112263252602"},{"key":"R24-1259","unstructured":"Pippard  EC,  Hall  AJ,  Barker  DJ, et al: Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.  Cancer Res 48:2929,1988-2932,"},{"key":"R25-1259","unstructured":"Swift  M,  Sholman  L,  Perry  M, et al: Malignant neoplasms in the families of patients with ataxia-telangiectasia.  Cancer Res 35:209,1976-215,"},{"key":"R26-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198705213162101"},{"key":"R27-1259","doi-asserted-by":"crossref","unstructured":"Swift  M,  Morrell  D,  Massey  RB, et al: Incidence of cancer in 161 families affected by ataxia-telangiectasia.  N Engl J Med 325:1381,1991-1386,","DOI":"10.1056\/NEJM199112263252602"},{"key":"R28-1259","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423"},{"key":"R29-1259","doi-asserted-by":"publisher","DOI":"10.1038\/ng0796-350"},{"key":"R32-1259","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201449"},{"key":"R33-1259","unstructured":"Artuso  M,  Esteve  A,  Bresil  H, et al: The role of the ataxia telangiectasia gene in the , (p21) and -mediated response to DNA damage produced by ionising radiation.  Oncogene 11:1427,1995-1435, p53 WAF1\/CIP GADD45"},{"key":"R34-1259","doi-asserted-by":"publisher","DOI":"10.1038\/387516a0"},{"key":"R35-1259","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00500-7"},{"key":"R36-1259","unstructured":"Khanna  KK,  Beamish  H,  Yan  J, et al: Nature of G1\/S cell cycle checkpoint defect in ataxia-telangiectasia.  Oncogene 11:609,1995-618,"},{"key":"R39-1259","doi-asserted-by":"publisher","DOI":"10.1038\/ng0897-397"},{"key":"R40-1259","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201793"},{"key":"R41-1259","doi-asserted-by":"publisher","DOI":"10.1101\/gad.10.19.2401"},{"key":"R42-1259","doi-asserted-by":"publisher","DOI":"10.1038\/ng0397-307"},{"key":"R43-1259","doi-asserted-by":"publisher","DOI":"10.1080\/09553009514551101"},{"key":"R44-1259","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(96)00328-7"},{"key":"R45-1259","doi-asserted-by":"publisher","DOI":"10.1007\/BF02619631"},{"key":"R46-1259","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2449"},{"key":"R47-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502163320709"},{"key":"R48-1259","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050270"},{"key":"R49-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502163320701"},{"key":"R50-1259","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.1.145"},{"key":"R51-1259","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.4.433"},{"key":"R52-1259","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<69::AID-HUMU11>3.0.CO;2-X"},{"key":"R53-1259","doi-asserted-by":"publisher","DOI":"10.1086\/301706"},{"key":"R54-1259","unstructured":"Telatar  M,  Wang  Z,  Udar  N, et al: Ataxia-telangiectasia: Mutations in  cDNA detected by protein-truncation screening.  Am J Hum Genet 59:40,1996-44, ATM"},{"key":"R55-1259","unstructured":"Vorechovsky  I,  Luo  L,  Lindblom  A, et al:  mutations in cancer families.  Cancer Res 56:4130,1996-4133, ATM"},{"key":"R56-1259","unstructured":"Wright  J,  Teraoka  S,  Onengut  S, et al: A high frequency of distinct  gene mutations in ataxia-telangiectasia.  Am J Hum Genet 59:839,1996-846, ATM"},{"key":"R57-1259","doi-asserted-by":"crossref","unstructured":"Land  CE,  Tokunaga  M,  Tokuoka  S, et al: Early-onset breast cancer in A-bomb survivors.  Lancet 342:237,1993,","DOI":"10.1016\/0140-6736(93)92324-M"},{"key":"R58-1259","doi-asserted-by":"publisher","DOI":"10.2307\/3578591"},{"key":"R59-1259","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530050042030"},{"key":"R60-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.338"},{"key":"R61-1259","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1662"},{"key":"R62-1259","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01116-1"},{"key":"R63-1259","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.110"},{"key":"R64-1259","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.14.1121"},{"key":"R65-1259","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.8.606"},{"key":"R66-1259","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205143262002"},{"key":"R67-1259","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116271"},{"key":"R68-1259","unstructured":"Strong  LC,  Stine  M,  Norsted  TL: Cancer in survivors of childhood soft tissue sarcoma and their relatives.  J Natl Cancer Inst 79:1213,1987-1220,"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.1999.17.4.1259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:32:31Z","timestamp":1653514351000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.1999.17.4.1259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["10.1200\/JCO.1999.17.4.1259"],"URL":"https:\/\/doi.org\/10.1200\/jco.1999.17.4.1259","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}